Fetal Description of the Pancreatic Agenesis and Holoprosencephaly Syndrome Associated to a Specific CNOT1 Variant

Pediatr Dev Pathol. 2022 Sep-Oct;25(5):548-552. doi: 10.1177/10935266221095305. Epub 2022 Apr 28.

Abstract

Holoprosencephaly (HPE) is a clinically and genetically heterogeneous disease, which can be associated with various prenatal comorbidities not always detectable on prenatal ultrasound. We report on the case of a foetus carrying a semi-lobar HPE diagnosed at ultrasound, for which a fetal autopsy and a whole exome sequencing were performed following a medical termination of pregnancy. Neuropathological examination confirmed the semi-lobar HPE and general autopsy disclosed a total pancreas agenesis. Whole exome sequencing found the CNOT1 missense c.1603C>T, p.(Arg535Cys), occurring de novo in the foetus. The same variant was previously reported in 5 unrelated children. All individuals had HPE, and 4 out of 5 presented endo- and exocrine pancreatic insufficiency or total pancreas agenesis. CNOT1 encodes a subunit of the CCRN4-NOT complex, expressed at the early stage of embryonic development. This report is the first fetal description of the phenotype associating HPE and pancreatic agenesis linked to the recurrent CNOT1 missense c.1603C>T, p.(Arg535Cys). This finding strengthens the hypothesis of a specific recurrent variant associated with a particular phenotype of HPE and pancreas agenesis. The fetal autopsy that revealed the pancreas agenesis was crucial in guiding the genetic diagnosis and enabling accurate genetic counselling.

Keywords: CNOT1; congenital malformation; fetal autopsy; holoprosencephaly; pancreas agenesis/hypoplasia; post-mortem examination.

MeSH terms

  • Female
  • Fetus / pathology
  • Holoprosencephaly* / diagnosis
  • Holoprosencephaly* / genetics
  • Holoprosencephaly* / pathology
  • Humans
  • Phenotype
  • Pregnancy
  • Syndrome
  • Transcription Factors / genetics

Substances

  • CNOT1 protein, human
  • Transcription Factors